Avantium (AVTX) investor relations material

Executive summary

• Achieved strong commercial momentum with 21 offtake agreements, 13 capacity reservations, and 1 license agreement for FDCA/PEF products; expanded partnerships with Tereos and LVMH GAÏA.

• FDCA Flagship Plant construction completed, but faced delays and additional capital expenditure; utilities and sugar dehydration units started up, with full start-up and commercial production targeted for mid-2026 and H2 2026.

• Secured comprehensive financing, including €85 million equity raise (with €15 million from Dutch Ministry of KGG) and additional €20 million targeted from government initiatives.

• Achieved ISO 14001, ISO 45001, and ISO 9001 certifications for the Flagship Plant, and secured key regulatory and recycling approvals in Europe and Japan.

• Announced nomination of Rogier van Wijk as CFO, effective May 2026, following a company-wide reorganization impacting about 40 positions.

Financial highlights

• FY25 revenues reached €58.6 million, up from €21.0 million in FY24, but other sources report a decline to €14.6 million due to license revenue suspension and lower R&D Solutions revenue.

• EBITDA improved to (€33.3) million from (€36.1) million year-over-year, though another source reports EBITDA at negative €36.1 million.

• Net loss for 2025 was €27.1 million, an improvement from €32.6 million in 2024.

• Cash position at year-end was €57.5 million, with borrowings at €131.5 million; cash up from €23.9 million due to equity raise and short-term financing.

• Investments totaled €14.6 million in FY25; net cash outflow from operating, investing, and financing activities was €61.4 million, down from €106.1 million in 2024.

Outlook and guidance

• Commercial scale production from the FDCA Flagship Plant expected in H2 2026, with sales under existing offtake agreements.

• Targeting four technology licenses in place by end of 2027.

• Clear path to profitable growth with EBITDA break-even and €90 million revenues in 2027.

• Additional government-related funding of €20 million anticipated, subject to approval.

• Strategic alternatives being evaluated for non-core technologies, including potential spin-outs and sales.